Novel quinazolinamide derivatives of the formula (I) in which R1 - R3 and X are each as defined in claim 1 are HSP90 inhibitors and can be used for production of a medicament for treatment of disorders in which the inhibition, regulation and/or modulation of HSP90 plays a role.
